For the quarter ending 2026-03-31, IRMD made $21,979,000 in revenue. $5,818,000 in net income. Net profit margin of 26.47%.
| Income Statement | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 21,979,000 | 21,202,064 | 20,409,400 | 19,510,637 |
| Cost of revenue | 5,165,000 | 4,707,756 | 4,454,408 | 4,667,831 |
| Gross profit | 16,814,000 | 16,494,308 | 15,954,992 | 14,842,806 |
| General and administrative | 4,569,000 | 4,355,636 | 4,279,993 | 4,610,832 |
| Sales and marketing | 4,052,000 | 4,630,560 | 4,009,640 | 4,176,273 |
| Research and development | 956,000 | 674,362 | 877,362 | 624,245 |
| Total operating expenses | 9,577,000 | 9,660,558 | 9,166,995 | 9,411,350 |
| Income from operations | 7,237,000 | 6,833,750 | 6,787,997 | 5,431,456 |
| Other income, net | 532,000 | 463,976 | 539,247 | 513,973 |
| Income before provision for income taxes | 7,769,000 | 7,297,726 | 7,327,244 | 5,945,429 |
| Provision for income tax expense | 1,951,000 | 1,721,074 | 1,553,283 | 1,258,000 |
| Net income | 5,818,000 | 5,576,652 | 5,773,961 | 4,687,429 |
| Basic EPS | 0.46 | 0.44 | 0.45 | 0.37 |
| Diluted EPS | 0.45 | 0.43 | 0.45 | 0.37 |
| Basic Average Shares | 12,783,000 | 12,720,812 | 12,715,872 | 12,714,224 |
| Diluted Average Shares | 12,870,000 | 12,860,077 | 12,835,408 | 12,825,672 |
IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD)